PROSPECTS FOR IMPROVEMENT OF ANTIBACTERIAL TREATMENT OF ACUTE RHINOSINUSITIS
- Authors: Nosulya E1, Nosulya E.V.1
-
Affiliations:
- Issue: No 10 (2010)
- Pages: 28-30
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278452
- ID: 278452
Cite item
Full Text
Abstract
Acute rhinosinusitis (ARS) is one of most common diseases of upper respiratory tract. The article presents information for the etiology, clinical manifestations, diagnostic methods and principles of treatment of this disease. The drug of choice for treatment of ARS is amoxicillin, and the use of amoxycillin/clavulanate slow-release provides higher activity against etiologically significant pathogens, which unfolds additional features for improvement of efficiency of antibiotic treatment of ARS.
References
- Anon JB, Jacobs MR, Poole MD. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(Suppl. 1):1-45.
- Козлов Р.С., Веселов А.В. Острый бактериальный риносинусит. В кн.: Внебольничные инфекции дыхательных путей. М., 2007. С. 145-66.
- Страчунский Л.С., Каманин Е.И., Тарасов А.А. Антибактериальная терапия синусита // Клиническая микробиология и антимикробная химиотерапия. 1999. Т. 1. № 1. С. 83-88.
- Riley L. Amoxicillin-clavulanate may be suitable for CAP. Infectious Diseases News 2005:28.
- File TM Jr. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults. J Antimicrob Agents 2007;30(Suppl. 2):S131-34.
Supplementary files
